Drug
Dnl201
Dnl201: highest development phase Phase 1, developed by Denali Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Denali Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| DNL201 NCT04551534 | Phase 1 | Healthy Volunteers |
| DNL201 NCT03710707 | Phase 1 | Parkinson Disease |
Latest
No recent events.
Follow Dnl201 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.